Welcome to our dedicated page for PLTXE news (Ticker: PLTXE), a resource for investors and traders seeking the latest updates and insights on PLTXE stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect PLTXE's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of PLTXE's position in the market.
PlantX Life Inc. reported $1,541,788 in monthly gross revenue for May 2022, a significant increase of 115% from $717,944 in May 2021. The Cost of Goods Sold for May was $1,002,162, indicating a continual growth trajectory in the plant-based e-commerce sector. CEO Lorne Rapkin praised the team’s commitment and outlined efforts towards achieving profitability. However, the company has withdrawn its application to list on the Toronto Stock Exchange due to adverse market conditions, continuing to trade on the CSE under the symbol VEGA, and OTCQX as PLTXF.